•$Anika Therapeutics (ANIK.US)$+5% (receives FDA 510(k) clearance for the X-Twist knotless fixation system expanding its sports medicine soft tissue portfolio)
•$Mirati Therapeutics (MRTX.US)$+3.2% (submits marketing authorization application for adagrasib to the EMA; also upgraded to Buy from Neutral at Guggenheim)
•$Atara Biotherapeutics (ATRA.US)$-3.1% (ATRA says Bayer (BAYR.Y) intends to end licensing agreement for next-gen mesothelin-directed CAR T-cell therapies)
•$Kohl's Corp (KSS.US)$-2.3% (Macellum Issues Statement Regarding the Kohl's Board's Apparent Breach of Fiduciary Duty and Failure to Disclose Material Information Prior to 2022 Annual Meeting)
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.